SCHEMBL11961329

SCHEMBL11961329

CBc1[nH]c2cc(C(=O)O)ccc2c1C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.43
KMO O15229 1/20 0.42
CCR3 P51677 1/20 0.39
CSNK2A1 P68400 2/20 0.39
DYRK1A Q13627 1/20 0.39
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
KIF11 P52732 1/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 5/20 0.36
HSD17B10 Q99714 3/20 0.36
GAA P10253 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HPGD P15428 3/20 0.36
THRB P10828 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
ENPP2 Q13822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12715624 0.87 PARP1 (0.48) PARP1CSNK2A1DYRK1AKIF11KMT2A
SCHEMBL11961347 0.84 GABRA1 (0.41) PARP1CSNK2A1KIF11KMT2AALDH1A1
SCHEMBL6076536 0.83 KDM4E (0.48) PARP1KMOCCR3CSNK2A1DYRK1A
SCHEMBL50743 0.81 PARP1 (0.46) PARP1KMOCCR3CSNK2A1DYRK1A
SCHEMBL10186873 0.81 PARP1 (0.46) PARP1KMOCCR3CSNK2A1DYRK1A
SCHEMBL14436046 0.81 NR1I2 (0.43)
SCHEMBL1173816 0.78 PARP1 (0.52) PARP1KMO
SCHEMBL19316500 0.76 PARP1 (0.42) PARP1KMOCCR3CSNK2A1DYRK1A
SCHEMBL5444969 0.75 KDM4E (0.46) PARP1KMT2AALDH1A1KDM4EGAA
SCHEMBL6387931 0.73 HTR2A (0.44) PARP1KMOCCR3CSNK2A1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2209784-B1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL MYERS SQUIBB CO (US) 2012-08-01 EP disclosed
EP-2121697-B1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL MYERS SQUIBB CO (US) 2011-08-31 EP disclosed
WO-2007092000-A1 INHIBITORS OF HCV REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2007-08-16 WO disclosed